• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Hospital Frequent Flyers Small Portion of Population Than Anticipated

Article

Policy makers who are creating initiatives to prevent the very costly and too frequent trips some patients take to the hospital may be examining a population that is actually smaller than they might realize.

Policy makers who are creating initiatives to prevent the very costly and too frequent trips some patients take to the hospital may be examining a population that is actually smaller than they might realize.

In a study published by Health Affairs, researchers found that super-utilizers, or patients who accumulate numerous emergency room visits and hospital admissions over a year span, made up just 3% of the 4774 adults examined in the study. Although they did account for 30% of adult charges.

Less than half of the adults who were characterized as super-utilizers at the start of the study were no longer labeled as such within 7 months from the start. By the end of the year, only 28% of adults in the super-utilizer group were still identified as a hospital frequent flyer. Most patient subgroups reduced their utilization when compared a year later, with the reduction in per person spending averaging 44%.

Of the super-utilizer group, researchers found that 82% of the adults had multiple comorbid chronic conditions, which includes mental health conditions.

“Instability in individual super-utilizer status has important implications for program design,” the authors wrote. “Interventions for individuals who have persistently high utilization are likely to be different from those for individuals with time-limited episodes of super-utilization.”

Recent policy initiatives have been looking to implement community and primary care-based interventions that are less expensive as a means to counter the high costs to the healthcare system super-utilizers are imposing.

“Population-level stability obscures significant instability at the individual level, which may have led to oversimplification of the problem in some policy discussions," the authors wrote.

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Stephanie L. Graff, MD, an expert on breast cancer
Debra Boyer, MD, MHPE, ATSF.
Ioana Preston, MD, a pulmonologist
B. Joy Snider, MD, PhD, and Maria Lopes, MD, MS
A panel of 5 experts on Alzheimer disease
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.